Exhibit 99.2
ASHLAND GLOBAL HOLDINGS INC. AND CONSOLIDATED SUBSIDIARIES
UNAUDITED CONDENSED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS
The following unaudited condensed pro forma consolidated financial statements are based upon the historical financial statements of Ashland Global Holdings Inc. and its consolidated subsidiaries (Ashland), adjusted to reflect the distribution to Ashland stockholders of an aggregate 170 million shares of Valvoline Inc. (Valvoline) common stock. The following unaudited condensed pro forma consolidated financial statements of Ashland should be read in conjunction with the related notes and with the historical consolidated financial statements of Ashland and the related notes included in previous filings with the Securities and Exchange Commission. The unaudited condensed pro forma consolidated balance sheet reflects the distribution of Valvoline as if it occurred on March 31, 2017 while the unaudited condensed pro forma statements of consolidated income give effect to the distribution as if it occurred on October 1, 2013, the beginning of the earliest period presented. The pro forma adjustments, described in the related notes, are based on the best available information and certain assumptions that Ashland management believe are reasonable. Actual amounts may differ from these estimated amounts.
Ashland Global Holdings Inc. and Consolidated Subsidiaries | | | | | | | | | | | | |
Unaudited Condensed Pro Forma Consolidated Balance Sheet | | | | | | | | | | | | |
March 31, 2017 | | | | | | | | | | | | |
| | | | | (a) | | | (d) | | | | |
(In millions) | | Historical | | | Valvoline | | | Adjustments | | | Pro Forma | |
| | | | | | | | | | | | |
ASSETS | | | | | | | | | | | | |
Current assets | | | | | | | | | | | | |
Cash and cash equivalents | | $ | 605 | | | $ | (135 | ) | | $ | - | | | $ | 470 | |
Accounts receivable | | | 972 | | | | (402 | ) | | | - | | | | 570 | |
Inventories | | | 687 | | | | (148 | ) | | | - | | | | 539 | |
Other assets | | | 113 | | | | (25 | ) | | | 11 | | | | 99 | |
Total current assets | | | 2,377 | | | | (710 | ) | | | 11 | | | | 1,678 | |
Noncurrent assets | | | | | | | | | | | | | | | | |
Property, plant and equipment | | | | | | | | | | | | | | | | |
Cost | | | 4,364 | | | | (765 | ) | | | - | | | | 3,599 | |
Accumulated depreciation | | | 2,159 | | | | (416 | ) | | | - | | | | 1,743 | |
Net property, plant and equipment | | | 2,205 | | | | (349 | ) | | | - | | | | 1,856 | |
Goodwill | | | 2,413 | | | | (312 | ) | | | - | | | | 2,101 | |
Intangibles | | | 1,017 | | | | (6 | ) | | | - | | | | 1,011 | |
Restricted investments | | | 298 | | | | - | | | | - | | | | 298 | |
Asbestos insurance receivable | | | 193 | | | | - | | | | - | | | | 193 | |
Equity and other unconsolidated investments | | | 61 | | | | (30 | ) | | | - | | | | 31 | |
Deferred income taxes | | | 199 | | | | - | | | | (163 | ) | | | 36 | |
Other assets | | | 423 | | | | (85 | ) | | | 77 | | | | 415 | |
Total noncurrent assets | | | 6,809 | | | | (782 | ) | | | (86 | ) | | | 5,941 | |
Total assets | | $ | 9,186 | | | $ | (1,492 | ) | | $ | (75 | ) | | $ | 7,619 | |
| | | | | | | | | | | | | | | | |
LIABILITIES AND EQUITY | | | | | | | | | | | | | | | | |
Current liabilities | | | | | | | | | | | | | | | | |
Short-term debt | | $ | 95 | | | $ | (75 | ) | | $ | - | | | $ | 20 | |
Current portion of long-term debt | | | 16 | | | | (16 | ) | | | - | | | | - | |
Trade and other payables | | | 520 | | | | (173 | ) | | | - | | | | 347 | |
Accrued expenses and other liabilities | | | 406 | | | | (181 | ) | | | 11 | | | | 236 | |
Total current liabilities | | | 1,037 | | | | (445 | ) | | | 11 | | | | 603 | |
Noncurrent liabilities | | | | | | | | | | | | | | | | |
Long-term debt | | | 2,812 | | | | (656 | ) | | | - | | | | 2,156 | |
Employee benefit obligations | | | 1,017 | | | | (833 | ) | | | - | | | | 184 | |
Asbestos litigation reserve | | | 663 | | | | - | | | | - | | | | 663 | |
Deferred income taxes | | | 69 | | | | 389 | | | | (163 | ) | | | 295 | |
Other liabilities | | | 445 | | | | (162 | ) | | | 77 | | | | 360 | |
Total noncurrent liabilities | | | 5,006 | | | | (1,262 | ) | | | (86 | ) | | | 3,658 | |
| | | | | | | | | | | | | | | | |
Equity | | | | | | | | | | | | | | | | |
Total Ashland stockholders' equity | | | 3,300 | | | | 58 | | | | - | | | | 3,358 | |
Noncontrolling interest | | | (157 | ) | | | 157 | | | | - | | | | - | |
Total equity | | | 3,143 | | | | 215 | | | | - | | | | 3,358 | |
Total liabilities and equity | | $ | 9,186 | | | $ | (1,492 | ) | | $ | (75 | ) | | $ | 7,619 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
See Notes to Unaudited Condensed Pro Forma Consolidated Financial Statements. | | | | | | | | | | | | | |
Ashland Global Holdings Inc. and Consolidated Subsidiaries | | | | | | | | | | |
Unaudited Condensed Pro Forma Statement of Consolidated Income | | | | | | | | | | |
Year ended September 30, 2016 | | | | | | | | | | |
| | | | | (b) | | | | | |
(In millions except per share data) | | Historical | | | Valvoline | | | Pro Forma | | |
| | | | | | | | | | |
| | | | | | | | | | |
Sales | | $ | 4,948 | | | $ | (1,929 | ) | | $ | 3,019 | | |
Cost of sales | | | 3,321 | | | | (1,168 | ) | | | 2,153 | | |
Gross profit | | | 1,627 | | | | (761 | ) | | | 866 | | |
| | | | | | | | | | | | | |
Selling, general and administrative expense | | | 1,228 | | | | (314 | ) | | | 914 | | |
Research and development expense | | | 100 | | | | (13 | ) | | | 87 | | |
Equity and other income | | | 28 | | | | (20 | ) | | | 8 | | |
Operating income (loss) | | | 327 | | | | (454 | ) | | | (127 | ) | |
| | | | | | | | | | | | | |
Net interest and other financing expense | | | 182 | | | | (9 | ) | | | 173 | | |
Net loss on divestitures | | | (9 | ) | | | 1 | | | | (8 | ) | |
Income (loss) from continuing operations before income taxes | | | 136 | | | | (444 | ) | | | (308 | ) | |
Income tax expense (benefit) | | | 133 | | | | (158 | ) | | | (25 | ) | |
Income (loss) from continuing operations | | $ | 3 | | | $ | (286 | ) | | $ | (283 | ) | |
| | | | | | | | | | | | | |
Earnings per share from continuing operations attributable to Ashland | | | | | | | | | | | | | |
Basic | | $ | 0.03 | | | | | | | $ | (4.51 | ) | |
Diluted | | | 0.03 | | | | | | | | (4.51 | ) | |
| | | | | | | | | | | | | |
Average common shares outstanding (in millions) | | | | | | | | | | | | | |
Basic | | | 63 | | | | | | | | 63 | | |
Diluted | | | 64 | | | | | | | | 63 | | (c) |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
See Notes to Unaudited Condensed Pro Forma Consolidated Financial Statements. | | | | | | | | | | |
Ashland Global Holdings Inc. and Consolidated Subsidiaries | | | | | | | | | | |
Unaudited Condensed Pro Forma Statement of Consolidated Income | | | | | | | | |
Year ended September 30, 2015 | | | | | | | | | | |
| | | | | (b) | | | | | |
(In millions except per share data) | | Historical | | | Valvoline | | | Pro Forma | | |
| | | | | | | | | | |
| | | | | | | | | | |
Sales | | $ | 5,387 | | | $ | (1,967 | ) | | $ | 3,420 | | |
Cost of sales | | | 3,814 | | | | (1,282 | ) | | | 2,532 | | |
Gross profit | | | 1,573 | | | | (685 | ) | | | 888 | | |
| | | | | | | | | | | | | |
Selling, general and administrative expense | | | 1,028 | | | | (336 | ) | | | 692 | | |
Research and development expense | | | 110 | | | | (11 | ) | | | 99 | | |
Equity and other income | | | 23 | | | | (8 | ) | | | 15 | | |
Operating income | | | 458 | | | | (346 | ) | | | 112 | | |
| | | | | | | | | | | | | |
Net interest and other financing expense | | | 174 | | | | - | | | | 174 | | |
Net loss on divestitures | | | (115 | ) | | | 26 | | | | (89 | ) | |
Income (loss) from continuing operations before income taxes | | | 169 | | | | (320 | ) | | | (151 | ) | |
Income tax benefit | | | (22 | ) | | | (117 | ) | | | (139 | ) | |
Income (loss) from continuing operations | | $ | 191 | | | $ | (203 | ) | | $ | (12 | ) | |
| | | | | | | | | | | | | |
Earnings per share from continuing operations | | | | | | | | | | | | | |
Basic | | $ | 2.81 | | | | | | | $ | (0.18 | ) | |
Diluted | | | 2.78 | | | | | | | | (0.18 | ) | |
| | | | | | | | | | | | | |
Average common shares outstanding (in millions) | | | | | | | | | | | | | |
Basic | | | 68 | | | | | | | | 68 | | |
Diluted | | | 69 | | | | | | | | 68 | | (c) |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
See Notes to Unaudited Condensed Pro Forma Consolidated Financial Statements. | | | | | | | | | | |
Ashland Global Holdings Inc. and Consolidated Subsidiaries | | | | | | | | | | |
Unaudited Condensed Pro Forma Statement of Consolidated Income | | | | | | | | |
Year ended September 30, 2014 | | | | | | | | | | |
| | | | | (b) | | | | | |
(In millions except per share data) | | Historical | | | Valvoline | | | Pro Forma | | |
| | | | | | | | | | |
| | | | | | | | | | |
Sales | | $ | 6,121 | | | $ | (2,041 | ) | | $ | 4,080 | | |
Cost of sales | | | 4,605 | | | | (1,409 | ) | | | 3,196 | | |
Gross profit | | | 1,516 | | | | (632 | ) | | | 884 | | |
| | | | | | | | | | | | | |
Selling, general and administrative expense | | | 1,358 | | | | (356 | ) | | | 1,002 | | |
Research and development expense | | | 114 | | | | (11 | ) | | | 103 | | |
Equity and other income (loss) | | | 2 | | | | (30 | ) | | | (28 | ) | |
Operating income (loss) | | | 46 | | | | (295 | ) | | | (249 | ) | |
| | | | | | | | | | | | | |
Net interest and other financing expense | | | 166 | | | | - | | | | 166 | | |
Net gain on divestitures | | | 4 | | | | - | | | | 4 | | |
Loss from continuing operations before income taxes | | | (116 | ) | | | (295 | ) | | | (411 | ) | |
Income tax benefit | | | (188 | ) | | | (102 | ) | | | (290 | ) | |
Income (loss) from continuing operations | | $ | 72 | | | $ | (193 | ) | | $ | (121 | ) | |
| | | | | | | | | | | | | |
Earnings per share from continuing operations | | | | | | | | | | | | | |
Basic | | $ | 0.94 | | | | | | | $ | (1.57 | ) | |
Diluted | | | 0.93 | | | | | | | | (1.57 | ) | |
| | | | | | | | | | | | | |
Average common shares outstanding (in millions) | | | | | | | | | | | | | |
Basic | | | 77 | | | | | | | | 77 | | |
Diluted | | | 78 | | | | | | | | 77 | | (c) |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
See Notes to Unaudited Condensed Pro Forma Consolidated Financial Statements. | | | | | | | | | | |